NCT01805089View on ClinicalTrials.gov

Melatonin Versus Placebo in Breast Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Breast Cancer
Interventions
DRUG

Melatonin 3 mg

Melatonin vs. Placebo

Trial Locations (2)

02215

Brigham and Women's Hospital, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT01805089 - Melatonin Versus Placebo in Breast Cancer | Biotech Hunter | Biotech Hunter